Takeda Pharmaceutical Company Limited Other Financial Liabilities
Takeda Pharmaceutical Company Limited (TKPHF) had Other Financial Liabilities of JPY 770.02 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:OtherFinancialLiabilities · last filed 2025-06-25
- 2025-03-31: Other Financial Liabilities 770.02B JPY.
- 2024-03-31: Other Financial Liabilities 831.25B JPY.
- 2023-03-31: Other Financial Liabilities 719.81B JPY.
- 2022-03-31: Other Financial Liabilities 665.01B JPY.
| Period end | Other Financial Liabilities | Other Financial Liabilities as first filed |
|---|---|---|
| 2025-03-31 | 770.02B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 831.25B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 719.81B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 665.01B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 765.73B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 494.83B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 287.42B JPY 20-F · filed 2020-06-24 | 283.13B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 120.84B JPY 20-F · filed 2019-06-27 |